🔎 Trials Near Me

Hjem › Nyrekreft (nyrecellekarcinom) › Michigan › Ann Arbor

Kliniske studier for Nyrekreft (nyrecellekarcinom) i Ann Arbor, MI

12 studier for Nyrekreft (nyrecellekarcinom) søker deltakere på steder i og rundt Ann Arbor (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • og 4 flere
Alder 40 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT05334069

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RekruttererFase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • Huron Gastroenterology PC, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • og 4 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

RekruttererFase 2
  • Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
  • University of Michigan Rogel Cancer Center, Ann Arbor
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • og 4 flere
Alder 18 og eldre · Alle kjønn · Oppdatert 18. sep. 2026 · NCT05327686

A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies

RekruttererFase 1
  • University of Michigan, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07195916

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

RekruttererFase 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT06661720

Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

RekruttererFase 1
  • University of Michigan, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 18. aug. 2026 · NCT06966024

Inulin Gel in Combination With Ipilimumab and Nivolumab for the Treatment of Metastatic or Locally Advanced Kidney Cell Cancer, ICON Trial

RekruttererFase 1/2
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 31. jul. 2026 · NCT06866262

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

RekruttererFase 3
  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi unna
  • Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 11. jun. 2026 · NCT07383441

Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

RekruttererFase 1
  • University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 4. jun. 2026 · NCT04777994

Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma

RekruttererFase 2
  • University of Michigan, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 20. mai 2026 · NCT06053658

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

RekruttererFase 1
  • University of Michigan Hospitals, Ann Arbor
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2025 · NCT06805825

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

RekruttererFase 3
  • University of Michigan Comprehensive Cancer Center, Ann Arbor
  • University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi unna
Alder 18 og eldre · Alle kjønn · Oppdatert 9. sep. 2025 · NCT04510597

Nyrekreft (nyrecellekarcinom)-studier i andre byer

Andre studier i Ann Arbor

Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.